Product Information
DOXYCYCLINE HYCLATE 75 MG TAB is a generic product labeled by Chartwell RX LLC, priced at $0.5482 per EA under NDC 62135090720. Its NADAC has been published 54 times since Sep 24, 2025.
FDA first approved this application on Jul 25, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Chartwell RX LLCNDC
62135090720
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOXYCYCLINE HYCLATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA205931FDA Approved
7/25/2014
TE Code
AB
On Market Since
7/25/2014
Pharmacological Classes
Price Statistics
The NADAC for DOXYCYCLINE HYCLATE 75 MG TAB has been published 54 times since Sep 24, 2025, and over the history we have for it it has risen 43.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5482 per EA |
|---|---|
| All-time high | $0.5482 (Sep 30, 2026) |
| All-time low | $0.3816 (Sep 24, 2025) |
| 52-week high | $0.5482 |
| 52-week low | $0.3816 |
| Median price | $0.3816 |
| Average price | $0.3878 |
| Largest weekly change | +43.6% (Sep 23, 2026) |
| Weeks tracked | 54 |
| Tracking since | Sep 24, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Doxycycline Hyclate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Doxycycline Hyclate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tetracycline-class Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOXYCYCLINE HYCLATE 75 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DOXYCYCLINE HYCLATE 75 MG TAB, manufactured by Chartwell RX LLC, is $0.5482 per EA (NDC 62135090720), effective Sep 30, 2026.
How has the price of DOXYCYCLINE HYCLATE 75 MG TAB changed over time?
Over the history we have for it, the NADAC for DOXYCYCLINE HYCLATE 75 MG TAB has risen 43.6%. It has been tracked across 54 weekly CMS publications since Sep 24, 2025.
What are the highest and lowest recorded NADAC prices for DOXYCYCLINE HYCLATE 75 MG TAB?
Since Sep 24, 2025, the NADAC for DOXYCYCLINE HYCLATE 75 MG TAB has ranged from a low of $0.3816 (Sep 24, 2025) to a high of $0.5482 (Sep 30, 2026), with a median of $0.3816 per EA.
Are there cheaper alternatives to DOXYCYCLINE HYCLATE 75 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of DOXYCYCLINE HYCLATE 75 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DOXYCYCLINE HYCLATE 75 MG TAB?
DOXYCYCLINE HYCLATE 75 MG TAB (NDC 62135090720) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.